A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The study design of this trial is a Dose-Block Randomized, Placebo controlled (Double-blind), Active Controlled(Open-label), Dose-escalation.
Epistemonikos ID: 6aa4779c44b5fac44ed22ae3ada2f5c42159dbe0
First added on: May 11, 2024